| SLNs | Solid lipid nanoparticles |
| NLCs | Nanostructured lipid carriers |
| ULVs | Unilamellar vesicles |
| MLVs | Multilamellar vesicles |
| PLNs | PEGylated-lipid nanoparticles |
| siRNA | Small interfering RNA |
| HCC | Hepatocellular carcinoma |
| P-gp | P-glycoprotein |
| RGD | Arginine-glycine-aspartic acid |
| CSLNs | Cationic solid lipid nanoparticles |
| DOPE | Dioleoylphosphatidylethanolamine |
| PG | Phosphatidylglycerol |
| PS | Phosphatidylserine |
| PC | Phosphatidylcholine |
| RES | Reticuloendothelial system |
| NIPAM | N-isopropylacrylamide |
| HT | Hyperthermia |
| Tm | Phase transition temperature |
| CMC | Critical micellar concentration |
| AuNPs | Gold nanoparticles |
| SPR | Surface plasmon resonance |
| SPIONs | Superparamagnetic iron oxide nanoparticles |
| MPI | Magnetic particle imaging |
| PEI | Poly(ethylenimine) |
| CST | Critical solution temperature |
| LCST | Lower critical solution temperatures |
| UCST | Upper critical solution temperature |
| NDV | Newcastle disease virus |
| ISCOMs | Immuno-stimulating complexes |
| FDA | Food and Drug Administration |
| NAP | Neuroprotective peptide |
| Lf | Lactoferrin |
| Pep-H | Peptide H |
| Mtb Ab | Mycobacterium tuberculosis Antibody |
| SEDDS | Self-emulsifying drug delivery system |
| SMDDS | Self-microemulsifying drug delivery system |
